Search

Benjamin J. Packard

Examiner (ID: 7369, Phone: (571)270-3440 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1609, 1612, 4173
Total Applications
1700
Issued Applications
945
Pending Applications
209
Abandoned Applications
578

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20656581 [patent_doc_number] => 20260108615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-23 [patent_title] => SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 18/697611 [patent_app_country] => US [patent_app_date] => 2022-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5829 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18697611 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/697611
SELF-ASSEMBLED MUCOADHESIVE BIOPOLYMER PARTICLE RELEASE SYSTEM AND PREPARATION METHOD THEREOF Sep 28, 2022 Pending
Array ( [id] => 18836745 [patent_doc_number] => 11844802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-19 [patent_title] => Compounds and compositions for ossification and methods related thereto [patent_app_type] => utility [patent_app_number] => 17/936184 [patent_app_country] => US [patent_app_date] => 2022-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 13557 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936184 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/936184
Compounds and compositions for ossification and methods related thereto Sep 27, 2022 Issued
Array ( [id] => 18460358 [patent_doc_number] => 11684636 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-06-27 [patent_title] => Stable, highly pure l-cysteine compositions for injection and methods of use [patent_app_type] => utility [patent_app_number] => 17/950979 [patent_app_country] => US [patent_app_date] => 2022-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28643 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950979 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/950979
Stable, highly pure l-cysteine compositions for injection and methods of use Sep 21, 2022 Issued
Array ( [id] => 18427624 [patent_doc_number] => 11672824 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-06-13 [patent_title] => Stable, highly pure L-cysteine compositions for injection and methods of use [patent_app_type] => utility [patent_app_number] => 17/950964 [patent_app_country] => US [patent_app_date] => 2022-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28639 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950964 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/950964
Stable, highly pure L-cysteine compositions for injection and methods of use Sep 21, 2022 Issued
Array ( [id] => 18209252 [patent_doc_number] => 20230055512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => METHOD OF TREATMENT OF TOPICAL DERMATOLOGIC ACNE USING A CREAM COMPOSITION AND METHOD OF MANUFACTURE [patent_app_type] => utility [patent_app_number] => 17/901688 [patent_app_country] => US [patent_app_date] => 2022-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901688 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/901688
Method of treatment of topical dermatologic acne using a cream composition and method of manufacture Aug 31, 2022 Issued
Array ( [id] => 18434176 [patent_doc_number] => 20230181470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION [patent_app_type] => utility [patent_app_number] => 17/822872 [patent_app_country] => US [patent_app_date] => 2022-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822872 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/822872
Compositions and methods for treating disorders ameliorated by muscarinic receptor activation Aug 28, 2022 Issued
Array ( [id] => 19798852 [patent_doc_number] => 20250064777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER COMPRISING BRUCEANTIN AND NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 18/700767 [patent_app_country] => US [patent_app_date] => 2022-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3487 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700767 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/700767
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER COMPRISING BRUCEANTIN AND NANOPARTICLES Aug 25, 2022 Pending
Array ( [id] => 18279307 [patent_doc_number] => 20230094779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => DRUG DELIVERY DEVICES FOR DELIVERY OF OCULAR THERAPEUTICS AGENTS [patent_app_type] => utility [patent_app_number] => 17/887261 [patent_app_country] => US [patent_app_date] => 2022-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22579 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17887261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/887261
DRUG DELIVERY DEVICES FOR DELIVERY OF OCULAR THERAPEUTICS AGENTS Aug 11, 2022 Abandoned
Array ( [id] => 18056257 [patent_doc_number] => 20220387343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => Transdermal Drug Delivery System [patent_app_type] => utility [patent_app_number] => 17/884727 [patent_app_country] => US [patent_app_date] => 2022-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884727 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/884727
Transdermal drug delivery system Aug 9, 2022 Issued
Array ( [id] => 18673154 [patent_doc_number] => 20230310644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => IONIZABLE LIPID COMPOUNDS, LIPID NANOPARTICLES COMPRISING SAME AND THERAPEUTIC USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/816427 [patent_app_country] => US [patent_app_date] => 2022-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18293 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816427 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/816427
Ionizable lipid compounds, lipid nanoparticles comprising same and therapeutic uses thereof Jul 31, 2022 Issued
Array ( [id] => 18019135 [patent_doc_number] => 20220370634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => POLYGLUTAMATED ANTIFOLATES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/875724 [patent_app_country] => US [patent_app_date] => 2022-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -64 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17875724 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/875724
Polyglutamated antifolates and uses thereof Jul 27, 2022 Issued
Array ( [id] => 19512182 [patent_doc_number] => 20240343868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => METHODS OF CROSSLINKING POLYMERS AND HYDROGEL MICROPARTICLES AND OF ENCAPSULATING BIOLOGICALLY ACTIVE COMPOUNDS, COMPOSITIONS MADE THEREFROM, AND DEVICES [patent_app_type] => utility [patent_app_number] => 18/580416 [patent_app_country] => US [patent_app_date] => 2022-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580416 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/580416
METHODS OF CROSSLINKING POLYMERS AND HYDROGEL MICROPARTICLES AND OF ENCAPSULATING BIOLOGICALLY ACTIVE COMPOUNDS, COMPOSITIONS MADE THEREFROM, AND DEVICES Jul 20, 2022 Pending
Array ( [id] => 18353939 [patent_doc_number] => 11642323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-09 [patent_title] => Method for modulating metabolism [patent_app_type] => utility [patent_app_number] => 17/813875 [patent_app_country] => US [patent_app_date] => 2022-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 13909 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813875 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/813875
Method for modulating metabolism Jul 19, 2022 Issued
Array ( [id] => 18626494 [patent_doc_number] => 20230285279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/812893 [patent_app_country] => US [patent_app_date] => 2022-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14843 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812893 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812893
BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF Jul 14, 2022 Abandoned
Array ( [id] => 19477233 [patent_doc_number] => 20240325275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => ORAL CARE COMPOSITIONS WITH PHOSPHOPEPTIDES FOR USE AGAINST DENTAL HYPERSENSITIVITY AND/OR XEROSTOMIA [patent_app_type] => utility [patent_app_number] => 18/579107 [patent_app_country] => US [patent_app_date] => 2022-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18579107 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/579107
ORAL CARE COMPOSITIONS WITH PHOSPHOPEPTIDES FOR USE AGAINST DENTAL HYPERSENSITIVITY AND/OR XEROSTOMIA Jul 10, 2022 Pending
Array ( [id] => 17944233 [patent_doc_number] => 20220331250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => HIGH-EFFICIENCY ENCAPSULATION OF HYDROPHILIC COMPOUNDS IN UNILAMELLAR LIPOSOMES [patent_app_type] => utility [patent_app_number] => 17/857302 [patent_app_country] => US [patent_app_date] => 2022-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9792 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857302 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/857302
High-efficiency encapsulation of hydrophilic compounds in unilamellar liposomes Jul 4, 2022 Issued
Array ( [id] => 18799995 [patent_doc_number] => 11833139 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-05 [patent_title] => Rifabutin treatment methods, uses, and compositions [patent_app_type] => utility [patent_app_number] => 17/833326 [patent_app_country] => US [patent_app_date] => 2022-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8759 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833326 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/833326
Rifabutin treatment methods, uses, and compositions Jun 5, 2022 Issued
Array ( [id] => 19387981 [patent_doc_number] => 20240277851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => siRNA DELIVERY VECTOR [patent_app_type] => utility [patent_app_number] => 18/562733 [patent_app_country] => US [patent_app_date] => 2022-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10012 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562733 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/562733
siRNA DELIVERY VECTOR Jun 2, 2022 Pending
Array ( [id] => 18227188 [patent_doc_number] => 20230066182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/826817 [patent_app_country] => US [patent_app_date] => 2022-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10215 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826817 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/826817
Rifabutin treatment methods, uses, and compositions May 26, 2022 Issued
Array ( [id] => 19570488 [patent_doc_number] => 20240374780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => ANTIMICROBIAL COMPONENT FOR A WOUND DRESSING [patent_app_type] => utility [patent_app_number] => 18/564143 [patent_app_country] => US [patent_app_date] => 2022-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8843 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564143 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/564143
ANTIMICROBIAL COMPONENT FOR A WOUND DRESSING May 26, 2022 Pending
Menu